FI970217A0 - Keinotekoisiin biologisiin välineisiin kapseloitujen solujen kasvun säätely - Google Patents
Keinotekoisiin biologisiin välineisiin kapseloitujen solujen kasvun säätelyInfo
- Publication number
- FI970217A0 FI970217A0 FI970217A FI970217A FI970217A0 FI 970217 A0 FI970217 A0 FI 970217A0 FI 970217 A FI970217 A FI 970217A FI 970217 A FI970217 A FI 970217A FI 970217 A0 FI970217 A0 FI 970217A0
- Authority
- FI
- Finland
- Prior art keywords
- encapsulated
- regulation
- cell growth
- artificial biological
- biological devices
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/383—Nerve cells, e.g. dendritic cells, Schwann cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/74—Alginate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/279,773 US5935849A (en) | 1994-07-20 | 1994-07-20 | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
US08/432,698 US5843431A (en) | 1994-07-20 | 1995-05-09 | Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation |
PCT/US1995/009281 WO1996002646A2 (en) | 1994-07-20 | 1995-07-20 | Growth control for cells encapsulated within bioartificial organs |
Publications (2)
Publication Number | Publication Date |
---|---|
FI970217A0 true FI970217A0 (fi) | 1997-01-17 |
FI970217A FI970217A (fi) | 1997-01-17 |
Family
ID=26959885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI970217A FI970217A (fi) | 1994-07-20 | 1997-01-17 | Keinotekoisiin biologisiin välineisiin kapseloitujen solujen kasvun säätely |
Country Status (20)
Country | Link |
---|---|
US (7) | US5795790A (zh) |
EP (1) | EP0771350A1 (zh) |
JP (3) | JPH10506266A (zh) |
CN (1) | CN1152938A (zh) |
AU (1) | AU698624B2 (zh) |
BR (1) | BR9508312A (zh) |
CA (1) | CA2195446C (zh) |
CZ (1) | CZ16397A3 (zh) |
EE (1) | EE9700018A (zh) |
FI (1) | FI970217A (zh) |
HU (1) | HUT77875A (zh) |
IL (1) | IL114671A0 (zh) |
IS (1) | IS4417A (zh) |
MX (1) | MX9700527A (zh) |
NO (1) | NO970156L (zh) |
NZ (1) | NZ290629A (zh) |
PL (1) | PL318288A1 (zh) |
SK (1) | SK7797A3 (zh) |
TR (1) | TR199500882A2 (zh) |
WO (1) | WO1996002646A2 (zh) |
Families Citing this family (191)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU720662B2 (en) * | 1995-04-07 | 2000-06-08 | Albert Einstein College Of Medicine Of Yeshiva University | Recombinant B-cell and uses thereof |
US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
US6692964B1 (en) | 1995-05-04 | 2004-02-17 | The United States Of America As Represented By The Secretary Of The Navy | Methods for transfecting T cells |
WO1996034970A1 (en) * | 1995-05-04 | 1996-11-07 | United States Of America, Represented By The Secretary Of The Navy | Improved methods for transfecting t cells |
US5837234A (en) * | 1995-06-07 | 1998-11-17 | Cytotherapeutics, Inc. | Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane |
US5855613A (en) | 1995-10-13 | 1999-01-05 | Islet Sheet Medical, Inc. | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change |
US6054142A (en) * | 1996-08-01 | 2000-04-25 | Cyto Therapeutics, Inc. | Biocompatible devices with foam scaffolds |
US6150164A (en) * | 1996-09-30 | 2000-11-21 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
CA2286590C (en) * | 1997-04-18 | 2005-08-02 | California Institute Of Technology | Multifunctional polymeric tissue coatings |
US6117643A (en) | 1997-11-25 | 2000-09-12 | Ut Battelle, Llc | Bioluminescent bioreporter integrated circuit |
US6872387B1 (en) | 1998-02-24 | 2005-03-29 | The Regents Of The University Of Michigan | Three-dimensional hydrogel/cell system |
DE19811574A1 (de) | 1998-03-17 | 1999-09-23 | Siemens Ag | Verfahren und Vorrichtung zum Überwachen der Funktionsfähigkeit eines Katalysators einer Brennkraftmaschine |
US6378527B1 (en) * | 1998-04-08 | 2002-04-30 | Chondros, Inc. | Cell-culture and polymer constructs |
US6303136B1 (en) | 1998-04-13 | 2001-10-16 | Neurotech S.A. | Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane |
US6171610B1 (en) * | 1998-04-24 | 2001-01-09 | University Of Massachusetts | Guided development and support of hydrogel-cell compositions |
US6027744A (en) * | 1998-04-24 | 2000-02-22 | University Of Massachusetts Medical Center | Guided development and support of hydrogel-cell compositions |
AU768269B2 (en) * | 1998-10-02 | 2003-12-04 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | Apoptosis inducing agents and methods |
US6197294B1 (en) * | 1998-10-26 | 2001-03-06 | Neurotech S.A. | Cell surface molecule-induced macrophage activation |
US6713293B1 (en) | 1999-02-08 | 2004-03-30 | Friedrich Grummt | Encapsulated cells containing an amplified expression vector as a drug delivery device |
US6903244B1 (en) | 1999-02-26 | 2005-06-07 | University Of Utah Research Foundation | Mice which are +/− or −/− for the elastin gene as models for vascular disease |
US6365385B1 (en) | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
US6303355B1 (en) | 1999-03-22 | 2001-10-16 | Duke University | Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
US6884628B2 (en) * | 1999-04-28 | 2005-04-26 | Eidgenossische Technische Hochschule Zurich | Multifunctional polymeric surface coatings in analytic and sensor devices |
AU1465801A (en) * | 1999-11-03 | 2001-05-14 | Oncotech, Inc. | Methods for cancer prognosis and diagnosis |
US7575921B2 (en) * | 1999-12-30 | 2009-08-18 | Vbi Technologies, L.L.C. | Spore-like cells and uses thereof |
US7560275B2 (en) * | 1999-12-30 | 2009-07-14 | Vbi Technologies, L.L.C. | Compositions and methods for generating skin |
EP1261357B1 (en) * | 2000-02-11 | 2010-07-14 | The Schepens Eye Research Institute, Inc. | Isolation and transplantation of retinal stem cells |
US6458589B1 (en) | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
US6719970B1 (en) * | 2000-07-10 | 2004-04-13 | Alkermes Controlled Therapeutics, Inc. | Method of generating cartilage |
EP1326968B1 (en) * | 2000-10-12 | 2007-04-18 | Agency for Science, Technology and Research | Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells |
WO2002057428A1 (en) * | 2000-10-30 | 2002-07-25 | University Of Massachusetts | Isolation of spore-like cells from tissues exposed to extreme conditions |
US6998234B2 (en) * | 2000-11-03 | 2006-02-14 | Oncotech, Inc. | Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells |
US6538010B1 (en) * | 2000-11-08 | 2003-03-25 | Research Triangle Institute | Compounds and methods for promoting smoking cessation |
JP3603103B2 (ja) * | 2000-11-15 | 2004-12-22 | 独立行政法人農業・生物系特定産業技術研究機構 | 動物(但し、ヒトを除く。)の受精卵の共培養担体及びこの担体を用いる動物(但し、ヒトを除く。)の受精卵の培養方法 |
US20020142304A1 (en) * | 2001-03-09 | 2002-10-03 | Anderson Daniel G. | Uses and methods of making microarrays of polymeric biomaterials |
US7858679B2 (en) * | 2001-07-20 | 2010-12-28 | Northwestern University | Polymeric compositions and related methods of use |
US7618937B2 (en) * | 2001-07-20 | 2009-11-17 | Northwestern University | Peptidomimetic polymers for antifouling surfaces |
US8815793B2 (en) * | 2001-07-20 | 2014-08-26 | Northwestern University | Polymeric compositions and related methods of use |
EP1281767A3 (en) | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
US7048934B2 (en) * | 2001-08-30 | 2006-05-23 | Stem Cell Therapeutics Inc. | Combined regulation of neural cell production |
US7332330B2 (en) | 2001-09-11 | 2008-02-19 | Renamed Biologics, Inc. | Device for maintaining vascularization near an implant |
CA2460184A1 (en) * | 2001-09-14 | 2003-03-27 | Stem Cell Therapeutics Inc. | Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
AU2002325710A1 (en) * | 2001-09-18 | 2003-04-01 | Stem Cell Therapeutics Inc. | Effect of growth hormone and igf-1 on neural stem cells and therapeutic application |
US20030109036A1 (en) * | 2001-12-06 | 2003-06-12 | The Regents Of The University Of California | Method for differentiating islet precursor cells into beta cells |
US7442546B2 (en) * | 2002-03-15 | 2008-10-28 | The Regents Of The University Of Michigan | Method of modulating inflammatory response |
AU2003228348A1 (en) * | 2002-03-20 | 2003-10-08 | John T. Fassett | Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
GB2387599B (en) * | 2002-04-17 | 2005-08-10 | Jason Peter Brown | Methods for producing antibodies |
US8187326B2 (en) * | 2002-05-22 | 2012-05-29 | Advanced Technologies And Regenerative Medicine, Llc. | Attachment of absorbable tissue scaffolds to fixation devices |
US20030228261A1 (en) * | 2002-06-05 | 2003-12-11 | Aladar Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
EP1369491A1 (en) | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
US7299805B2 (en) | 2002-06-07 | 2007-11-27 | Marctec, Llc | Scaffold and method for implanting cells |
US20030228287A1 (en) * | 2002-06-07 | 2003-12-11 | Regents Of The University Of California | Maintenance of islet cells |
US8911831B2 (en) * | 2002-07-19 | 2014-12-16 | Northwestern University | Surface independent, surface-modifying, multifunctional coatings and applications thereof |
DE10234742A1 (de) * | 2002-07-30 | 2004-02-19 | Bionethos Holding | Verfahren und Vorrichtung zum Züchten von Zellen |
AU2003250705A1 (en) * | 2002-07-31 | 2004-02-16 | Stem Cell Therapeutics Inc. | Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
US20040054414A1 (en) * | 2002-09-18 | 2004-03-18 | Trieu Hai H. | Collagen-based materials and methods for augmenting intervertebral discs |
US7744651B2 (en) * | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
JP2006515765A (ja) * | 2002-11-15 | 2006-06-08 | エスディージーアイ・ホールディングス・インコーポレーテッド | 滑膜性関節を治療するためのコラーゲンベース材料および方法 |
AU2003291093A1 (en) * | 2002-11-19 | 2004-06-15 | The Board Of Trustees Of The University Of Illinois | Multilayered microcultures |
AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
US20040186471A1 (en) * | 2002-12-07 | 2004-09-23 | Sdgi Holdings, Inc. | Method and apparatus for intervertebral disc expansion |
AU2003294541A1 (en) * | 2002-12-24 | 2004-07-22 | An-Go-Gen Inc. | Encapsulated cell for therapy |
WO2004094602A2 (en) * | 2003-04-16 | 2004-11-04 | Emory University | Combinatorial surface chip compositions for selection, differentiation and propagation of cells |
RU2376371C2 (ru) | 2003-06-18 | 2009-12-20 | Дженелюкс Корпорейшн | Модифицированные рекомбинантные вакцинирующие вирусы и другие микроорганизмы и их применение |
US7651596B2 (en) | 2005-04-08 | 2010-01-26 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
WO2005020677A1 (en) | 2003-08-29 | 2005-03-10 | The Walter And Eliza Hall Institute Of Medical Research | Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
JP2007516984A (ja) | 2003-12-24 | 2007-06-28 | ザ ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ | 治療用物質およびそのための用途 |
ES2392282T3 (es) | 2004-02-13 | 2012-12-07 | Stem Cell Therapeutics Corp. | Uso de la hormona luteinizante (LH) y de la gonadotropina coriónica (hCG) para la proliferación de células precursoras neurales y la neurogénesis |
WO2009048462A1 (en) | 2007-10-09 | 2009-04-16 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US20050202096A1 (en) * | 2004-03-09 | 2005-09-15 | Jun Li | Microcapsules for encapsulation of bioactive substances |
WO2005099758A2 (en) * | 2004-04-17 | 2005-10-27 | The Board Of Trustees The Leland Standford Junior University | Injectable bioartificial tissue matrix |
WO2005108981A1 (en) | 2004-05-12 | 2005-11-17 | The Walter And Eliza Hall Institute Of Medical Research | A method of cell isolation |
US20060020192A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
CN101137347A (zh) * | 2004-11-16 | 2008-03-05 | 列日大学 | 包含水凝胶基质和微载体的活性物质递送系统 |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
WO2006102902A1 (en) * | 2005-04-01 | 2006-10-05 | Nsgene A/S | A human immortalised neural precursor cell line |
US8744546B2 (en) * | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
WO2006121661A2 (en) * | 2005-05-05 | 2006-11-16 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
ES2653844T3 (es) * | 2005-05-17 | 2018-02-09 | Gloriana Therapeutics Sarl | Un sistema de terapia implantable para tratar a un ser vivo con un factor activo |
WO2006138380A2 (en) * | 2005-06-15 | 2006-12-28 | Massachusetts Institute Of Technology | Amine-containing lipids and uses thereof |
WO2006135985A1 (en) | 2005-06-24 | 2006-12-28 | The Walter And Eliza Hall Institute Of Medical Research | Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
KR20080074108A (ko) | 2005-09-27 | 2008-08-12 | 스템 셀 테라퓨틱스 코포레이션 | 프로락틴에 의해 조절되는 올리고덴드로사이트 전구체 세포증식 |
US9388382B2 (en) * | 2005-10-05 | 2016-07-12 | The Board Of Trustees Of The University Of Illinois | Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells |
WO2008048671A1 (en) * | 2006-10-18 | 2008-04-24 | University Of Illinois | Embryonic-like stem cells derived from adult human peripheral blood and methods of use |
EP2004796B1 (en) * | 2006-01-18 | 2015-04-08 | DexCom, Inc. | Membranes for an analyte sensor |
US7732539B2 (en) * | 2006-02-16 | 2010-06-08 | National Science Foundation | Modified acrylic block copolymers for hydrogels and pressure sensitive wet adhesives |
AU2007229301B2 (en) * | 2006-03-17 | 2013-08-01 | Stem Cell Therapeutics Corp. | Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
US8118779B2 (en) * | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
US20080004703A1 (en) * | 2006-06-30 | 2008-01-03 | Warsaw Orthopedic, Inc. | Method of treating a patient using a collagen material |
US20080004431A1 (en) * | 2006-06-30 | 2008-01-03 | Warsaw Orthopedic Inc | Method of manufacturing an injectable collagen material |
US8399619B2 (en) * | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
CA2657532C (en) | 2006-07-18 | 2019-06-18 | University Of Utah Research Foundation | Methods for treating pain and screening analgesic compounds |
WO2008091386A2 (en) * | 2006-08-04 | 2008-07-31 | Northwestern University | Biomimetic modular adhesive complex: material, methods and applications therefore |
US7622533B2 (en) | 2006-08-04 | 2009-11-24 | Nerites Corporation | Biomimetic compounds and synthetic methods therefor |
KR100770440B1 (ko) * | 2006-08-29 | 2007-10-26 | 삼성전기주식회사 | 질화물 반도체 발광소자 |
EP1895012A1 (en) | 2006-08-30 | 2008-03-05 | Universitätsklinikum Freiburg | Method for inducing tumor apoptosis by increasing nitric oxide levels |
WO2008089032A1 (en) * | 2007-01-11 | 2008-07-24 | Northwestern University | Fouling resistant coatings and methods of making same |
US8673286B2 (en) | 2007-04-09 | 2014-03-18 | Northwestern University | DOPA-functionalized, branched, poly(aklylene oxide) adhesives |
US8383092B2 (en) * | 2007-02-16 | 2013-02-26 | Knc Ner Acquisition Sub, Inc. | Bioadhesive constructs |
CN101796186B (zh) | 2007-06-07 | 2013-05-22 | 韦克福里斯特大学健康科学院 | 喷墨基因打印 |
US20080306434A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
DK2173859T3 (en) * | 2007-06-29 | 2016-08-22 | Makoto Funaki | Soft-gel systems for the modulation of stem cell development |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
CA2715628A1 (en) * | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US20110143433A1 (en) * | 2008-03-17 | 2011-06-16 | Agency For Science, Technology And Research | Microcarriers for Stem Cell Culture |
US8716018B2 (en) * | 2008-03-17 | 2014-05-06 | Agency For Science, Technology And Research | Microcarriers for stem cell culture |
US8828720B2 (en) * | 2008-03-17 | 2014-09-09 | Agency For Science, Technology And Research | Microcarriers for stem cell culture |
US9458431B2 (en) | 2008-03-17 | 2016-10-04 | Agency For Science, Technology And Research | Microcarriers for stem cell culture |
US8691569B2 (en) * | 2008-03-17 | 2014-04-08 | Agency For Science, Technology And Research | Microcarriers for stem cell culture |
WO2009125332A1 (en) * | 2008-04-07 | 2009-10-15 | Peter Bromley | New and safe procedure for immunization against infectious diseases agents |
CN102245559B (zh) | 2008-11-07 | 2015-05-27 | 麻省理工学院 | 氨基醇类脂质和其用途 |
US20100125265A1 (en) * | 2008-11-20 | 2010-05-20 | Medtronic Vascular, Inc. | Cell Delivery System to Induce Cell Growth and Angiogenesis |
WO2010083841A2 (en) | 2009-01-23 | 2010-07-29 | Nsgene A/S | Improved cell lines and their use in encapsulated cell biodelivery |
US9150829B2 (en) | 2009-03-20 | 2015-10-06 | Agency For Science, Technoloy And Research | Culture of pluripotent and multipotent cells on microcarriers |
LT2470228T (lt) | 2009-08-28 | 2018-02-12 | Sernova Corporation | Būdai ir įrenginiai ląstelinei transplantacijai |
CN102573860A (zh) | 2009-10-02 | 2012-07-11 | 巴克斯特国际公司 | 用于治疗肾脏损伤的造血干细胞 |
KR102081356B1 (ko) | 2009-11-12 | 2020-02-25 | 브이셀 세라퓨틱스 인코포레이티드 | 포자를 닮은 세포들의 계군 및 그 용도 |
US20110130465A1 (en) * | 2009-12-01 | 2011-06-02 | Nerites Corporation | Coatings for prevention of biofilms |
US20110244026A1 (en) | 2009-12-01 | 2011-10-06 | Braydon Charles Guild | Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
EP2609135A4 (en) | 2010-08-26 | 2015-05-20 | Massachusetts Inst Technology | POLY (BETA-AMINO ALCOHOLS), THEIR PREPARATION AND USES THEREOF |
EP2625577B1 (en) | 2010-10-08 | 2019-06-26 | Terumo BCT, Inc. | Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
CA2817215C (en) | 2010-11-09 | 2017-05-09 | Knc Ner Acquisition Sub, Inc. | Adhesive compounds for use in hernia repair |
EP2646468B1 (en) | 2010-12-01 | 2018-07-25 | AlderBio Holdings LLC | Anti-ngf compositions and use thereof |
US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
KR20140091651A (ko) | 2010-12-02 | 2014-07-22 | 뉴로테크 유에스에이, 인코포레이티드. | 항-혈관 신생 항체-스캐폴드 및 가용성 수용체를 분비하는 세포주 및 이의 용도 |
US9238716B2 (en) | 2011-03-28 | 2016-01-19 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
AU2012267531B2 (en) | 2011-06-08 | 2017-06-22 | Translate Bio, Inc. | Lipid nanoparticle compositions and methods for mRNA delivery |
CN102350008A (zh) | 2011-10-25 | 2012-02-15 | 微创医疗器械(上海)有限公司 | 一种处理动物源性胶原纤维材料的方法 |
WO2013123292A1 (en) | 2012-02-17 | 2013-08-22 | The Schepens Eye Research Institute | Phenotype profile of human retinal progenitor cells |
EP2817014A2 (en) | 2012-02-21 | 2014-12-31 | Baxter International Inc | Pharmaceutical composition comprising cd34+ cells |
US20150150796A1 (en) | 2012-05-30 | 2015-06-04 | Neurotech Usa, Inc. | Cryopreserved Implantable Cell Culture Devices and Uses Thereof |
US20150267192A1 (en) | 2012-06-08 | 2015-09-24 | Shire Human Genetic Therapies, Inc. | Nuclease resistant polynucleotides and uses thereof |
CA2884870C (en) | 2012-08-13 | 2022-03-29 | Massachusetts Institute Of Technology | Amine-containing lipidoids and uses thereof |
US20140242595A1 (en) | 2013-02-22 | 2014-08-28 | Cellular Dynamics International, Inc. | Hepatocyte production via forward programming by combined genetic and chemical engineering |
EP3467108B1 (en) | 2013-03-14 | 2024-05-22 | Translate Bio, Inc. | Methods for purification of messenger rna |
IL290953B2 (en) | 2013-03-14 | 2024-01-01 | Ethris Gmbh | CFTR mRNA Assemblies and Related Methods and Uses |
WO2014144125A1 (en) | 2013-03-15 | 2014-09-18 | The Broad Institute, Inc. | Compounds for inducing proliferation and differentiation of cells, and methods of use thereof |
US9888680B2 (en) | 2013-04-04 | 2018-02-13 | The Trustees Of Columbia University In The City Of New York | Functional recovery of human lungs for transplantation |
US9315472B2 (en) | 2013-05-01 | 2016-04-19 | Massachusetts Institute Of Technology | 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
JP2016523125A (ja) | 2013-05-30 | 2016-08-08 | グラハム エイチ. クリーシー | 局所神経性刺激 |
US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
CA2913993A1 (en) | 2013-05-31 | 2014-12-04 | University Of Utah Research Foundation | Conotoxin peptides, pharmaceutical compositions and uses thereof |
US20150044259A1 (en) * | 2013-08-08 | 2015-02-12 | Mauris N. DeSilva | Scaffold for enhanced neural tissue regeneration |
ES2950987T3 (es) | 2013-09-11 | 2023-10-17 | Neurotech Usa Inc | Cartucho para terapia con células encapsuladas |
US9522176B2 (en) | 2013-10-22 | 2016-12-20 | Shire Human Genetic Therapies, Inc. | MRNA therapy for phenylketonuria |
KR102096796B1 (ko) | 2013-10-22 | 2020-05-27 | 샤이어 휴먼 지네틱 테라피즈 인크. | 메신저 rna의 전달을 위한 지질 제형 |
ES2707966T3 (es) | 2013-10-22 | 2019-04-08 | Translate Bio Inc | Terapia de ARNm para la deficiencia en síntesis de argininosuccinato |
EP3068866B1 (en) | 2013-11-16 | 2018-04-25 | Terumo BCT, Inc. | Expanding cells in a bioreactor |
EP3613841B1 (en) | 2014-03-25 | 2022-04-20 | Terumo BCT, Inc. | Passive replacement of media |
WO2015164228A1 (en) | 2014-04-21 | 2015-10-29 | Cellular Dynamics International, Inc. | Hepatocyte production via forward programming by combined genetic and chemical engineering |
EA201691696A1 (ru) | 2014-04-25 | 2017-03-31 | Шир Хьюман Дженетик Терапис, Инк. | Способы очистки матричной рнк |
CA2949106C (en) | 2014-05-30 | 2023-10-24 | Shire Human Genetic Therapies, Inc. | Biodegradable lipids for delivery of nucleic acids |
PE20171238A1 (es) | 2014-06-24 | 2017-08-24 | Shire Human Genetic Therapies | Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos |
WO2016004202A1 (en) | 2014-07-02 | 2016-01-07 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
CN106715676A (zh) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | 按计划供养 |
US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
US10456356B2 (en) | 2015-05-27 | 2019-10-29 | Neurotech Usa, Inc. | Use of encapsulated cell therapy for treatment of ophthalmic disorders |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
EP3352783B1 (en) | 2015-09-25 | 2021-08-25 | MaxiVAX SA | Vaccine comprising immuno-isolated cells producing an immunomodulator |
WO2017070145A1 (en) | 2015-10-19 | 2017-04-27 | Cellular Dynamics International, Inc. | Production of virus-receptive pluripotent stem cell (psc)-derived hepatocytes |
ES2959601T3 (es) | 2015-10-27 | 2024-02-27 | Univ Queensland | Un polipéptido EphA4 modificado |
JP6694512B2 (ja) | 2015-12-30 | 2020-05-13 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | 幹細胞由来ヒト肝細胞を使用した微小組織形成 |
CN109415696A (zh) | 2016-05-25 | 2019-03-01 | 泰尔茂比司特公司 | 细胞扩增 |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
CN106497877A (zh) * | 2016-11-01 | 2017-03-15 | 南方医科大学 | 一种促进骨髓间充质干细胞向神经诱导分化的基质材料 |
MA47603A (fr) | 2017-02-27 | 2020-01-01 | Translate Bio Inc | Nouvel arnm cftr à codons optimisés |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
CN117247899A (zh) | 2017-03-31 | 2023-12-19 | 泰尔茂比司特公司 | 细胞扩增 |
AU2018268859A1 (en) | 2017-05-16 | 2019-12-12 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding CFTR |
CN212438615U (zh) | 2017-10-24 | 2021-02-02 | 德克斯康公司 | 可穿戴设备 |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
CN111601636A (zh) | 2017-11-07 | 2020-08-28 | Oab神经电疗科技公司 | 具有自适应电路的非侵入性神经激活器 |
CN112930396B (zh) | 2018-08-24 | 2024-05-24 | 川斯勒佰尔公司 | 用于纯化信使rna的方法 |
WO2020227711A1 (en) | 2019-05-09 | 2020-11-12 | FUJIFILM Cellular Dynamics, Inc. | Methods for the production of hepatocytes |
KR20220025834A (ko) | 2019-06-26 | 2022-03-03 | 뉴로스팀 테크놀로지스 엘엘씨 | 적응적 회로를 갖는 비침습적 신경 활성화기 |
EP4017580A4 (en) | 2019-12-16 | 2023-09-06 | Neurostim Technologies LLC | NON-INVASIVE NERVE ACTIVATOR WITH AMPLIFIED CHARGE DISTRIBUTION |
US20230383261A1 (en) | 2020-10-14 | 2023-11-30 | Sana Biotechnology, Inc. | Hepatocyte-like cells |
WO2022235869A1 (en) | 2021-05-07 | 2022-11-10 | Astellas Institute For Regenerative Medicine | Methods of generating mature hepatocytes |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4391909A (en) * | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
US4495288A (en) * | 1981-03-13 | 1985-01-22 | Damon Biotech, Inc. | Method of culturing anchorage dependent cells |
US4402694A (en) * | 1981-07-16 | 1983-09-06 | Biotek, Inc. | Body cavity access device containing a hormone source |
US4485096A (en) * | 1982-02-26 | 1984-11-27 | Massachusetts Institute Of Technology | Tissue-equivalent and method for preparation thereof |
US4479796A (en) * | 1982-11-15 | 1984-10-30 | Medtronic, Inc. | Self-regenerating drug administration device |
US4489796A (en) * | 1983-05-25 | 1984-12-25 | Gte Laboratories Incorporated | Insert for a mine tool roof bit and a method of drilling therewith |
IL75554A (en) | 1985-06-18 | 1993-01-14 | Yeda Res & Dev | Matrix for cell cultivation in vitro |
US4829000A (en) * | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
US5049493A (en) * | 1987-10-23 | 1991-09-17 | California Institute Of Technology | Enhancement of cell growth by expression of a cloned hemoglobin gene |
US5156844A (en) * | 1987-11-17 | 1992-10-20 | Brown University Research Foundation | Neurological therapy system |
US5106627A (en) * | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
US5158881A (en) * | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
US5283187A (en) * | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
US5182111A (en) * | 1987-11-17 | 1993-01-26 | Boston University Research Foundation | In vivo delivery of active factors by co-cultured cell implants |
DE68907220T2 (de) * | 1988-04-12 | 1994-01-27 | Massachusetts Inst Technology | Verfahren zur manipulation des zelltyps von eukaryonten. |
US5270191A (en) * | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5250414A (en) | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
US5082670A (en) | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
CA2058955A1 (en) | 1989-06-13 | 1990-12-14 | Helen Blau | Isolation growth and differentiation of human muscle cells |
US5538722A (en) * | 1989-06-13 | 1996-07-23 | Stanford University | Isolation, growth, differentiation and genetic engineering of human muscle cells |
WO1991000119A1 (en) * | 1989-06-30 | 1991-01-10 | Baxter International Inc. | Implantable device |
US5053332A (en) * | 1989-07-24 | 1991-10-01 | Cook Richard B | Agarose beads, preferably incorporating biological materials |
US5354736A (en) * | 1989-08-14 | 1994-10-11 | Regents Of The University Of California | Synthetic compounds and compositions with enhanced cell binding |
US5002661A (en) * | 1989-08-25 | 1991-03-26 | W. R. Grace & Co.-Conn. | Artificial pancreatic perfusion device |
GB8928884D0 (en) | 1989-12-21 | 1990-02-28 | Feldmann Marc | Transformed cell lines |
GB9003791D0 (en) | 1990-02-20 | 1990-04-18 | Ludwig Inst Cancer Res | Transgenic animals,cell lines therefrom,and their use |
US5101319A (en) * | 1990-04-03 | 1992-03-31 | Vistatech Corporation | Pre-engineered electrode/dielectric composite film and related manufacturing process for multilayer ceramic chip capacitors |
DE4123629A1 (de) | 1990-08-06 | 1992-02-20 | Jakob Dr Bodziony | Ein implantierbares und biologisch aktive substanzen sezernierendes bio-artifizielles organ, das auf dem prinzip des druckgradients funktioniert |
WO1992003536A1 (en) * | 1990-08-15 | 1992-03-05 | University Of Miami And Its School Of Medicine | Autotransplantation of schwann cells to promote nervous system repair |
JP4215273B2 (ja) | 1991-04-25 | 2009-01-28 | ブラウン ユニヴァーシティ リサーチ ファンデーション | 選択された治療物質放出用の移植可能で生体適合性の免疫遮断性ビークル |
CA2111978A1 (en) * | 1991-06-28 | 1993-01-07 | Patrick Aebischer | Renewable neural implant device and method |
SG47451A1 (en) * | 1991-06-28 | 1998-04-17 | Univ Brown Res Found | Implantable therapy system |
DE69233061T3 (de) | 1991-07-08 | 2008-07-10 | Neurospheres Holding Ltd., Calgary | Auf wachstumsfaktoren reagierende neurale vorläuferzellen, die in vitro vermehrt werden können. |
AU2502592A (en) * | 1991-08-23 | 1993-03-16 | Denise Faustman | Implantable immunoisolated therapeutic devices |
CA2128630A1 (en) * | 1992-01-23 | 1993-08-05 | Bruce D. Cherksey | A method for transplanting cells into the brain and therapeutic uses therefor |
CA2134088A1 (en) * | 1992-04-24 | 1993-11-11 | Robert S. Ward | Method of culturing viable cells and method of regulating the level of a compound in a body fluid |
AU4114993A (en) | 1992-04-24 | 1993-11-29 | Polymer Technology Group, Inc., The | Biocompatible, therapeutic, implantable device |
DE69334150T2 (de) * | 1992-05-14 | 2008-03-13 | Baylor College Of Medicine, Houston | Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie |
CA2137456A1 (en) * | 1992-07-02 | 1994-01-20 | Inder Verma | Use of myoblasts for sustained delivery of gene products |
AU4995193A (en) * | 1992-08-04 | 1994-03-03 | Regeneron Pharmaceuticals, Inc. | Method of enhancing differentiation and survival of neuronal precursor cells |
US5489743A (en) * | 1993-01-19 | 1996-02-06 | Amgen Inc. | Transgenic animal models for thrombocytopenia |
ES2140359T1 (es) * | 1993-06-14 | 2000-03-01 | Basf Ag | Control preciso de expresion genetica en celulas eucarioticas mediante promotores que responden a la tetaciclina. |
EP1179350A3 (en) * | 1993-08-12 | 2003-01-02 | Cytotherapeutics, Inc. | Encapsulated cell system for implantation into the human CNS |
US5453368A (en) * | 1993-08-27 | 1995-09-26 | Brown University Research Foundation | Method of encapsulating biological substances in microspheres |
US5550050A (en) * | 1994-04-15 | 1996-08-27 | Cytotherapeutics, Inc. | Method for implanting encapsulated cells in a host |
-
1995
- 1995-05-23 US US08/448,201 patent/US5795790A/en not_active Expired - Lifetime
- 1995-05-23 US US08/447,997 patent/US6392118B1/en not_active Expired - Fee Related
- 1995-05-23 US US08/447,771 patent/US5833979A/en not_active Expired - Lifetime
- 1995-05-23 US US08/447,810 patent/US5858747A/en not_active Expired - Fee Related
- 1995-05-23 US US08/447,356 patent/US5853717A/en not_active Expired - Fee Related
- 1995-05-23 US US08/445,193 patent/US5840576A/en not_active Expired - Lifetime
- 1995-05-23 US US08/447,778 patent/US5776747A/en not_active Expired - Lifetime
- 1995-07-19 IL IL11467195A patent/IL114671A0/xx unknown
- 1995-07-20 WO PCT/US1995/009281 patent/WO1996002646A2/en not_active Application Discontinuation
- 1995-07-20 BR BR9508312A patent/BR9508312A/pt unknown
- 1995-07-20 CZ CZ97163A patent/CZ16397A3/cs unknown
- 1995-07-20 PL PL95318288A patent/PL318288A1/xx unknown
- 1995-07-20 SK SK77-97A patent/SK7797A3/sk unknown
- 1995-07-20 AU AU31422/95A patent/AU698624B2/en not_active Ceased
- 1995-07-20 EE EE9700018A patent/EE9700018A/xx unknown
- 1995-07-20 JP JP8505271A patent/JPH10506266A/ja active Pending
- 1995-07-20 MX MX9700527A patent/MX9700527A/es unknown
- 1995-07-20 NZ NZ290629A patent/NZ290629A/xx unknown
- 1995-07-20 TR TR95/00882A patent/TR199500882A2/xx unknown
- 1995-07-20 CN CN95194187A patent/CN1152938A/zh active Pending
- 1995-07-20 CA CA2195446A patent/CA2195446C/en not_active Expired - Fee Related
- 1995-07-20 HU HU9700181A patent/HUT77875A/hu unknown
- 1995-07-20 EP EP95927373A patent/EP0771350A1/en not_active Ceased
-
1997
- 1997-01-14 NO NO970156A patent/NO970156L/no not_active Application Discontinuation
- 1997-01-17 IS IS4417A patent/IS4417A/is unknown
- 1997-01-17 FI FI970217A patent/FI970217A/fi unknown
-
2005
- 2005-02-10 JP JP2005035315A patent/JP2005224614A/ja active Pending
-
2006
- 2006-02-08 JP JP2006031612A patent/JP2006198414A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US6392118B1 (en) | 2002-05-21 |
US5840576A (en) | 1998-11-24 |
NZ290629A (en) | 1998-10-28 |
EE9700018A (et) | 1997-06-16 |
CA2195446C (en) | 2010-05-25 |
IS4417A (is) | 1997-01-17 |
HUT77875A (hu) | 1998-09-28 |
CA2195446A1 (en) | 1996-02-01 |
CZ16397A3 (cs) | 1998-03-18 |
JP2006198414A (ja) | 2006-08-03 |
BR9508312A (pt) | 1999-06-01 |
US5858747A (en) | 1999-01-12 |
MX9700527A (es) | 1997-04-30 |
WO1996002646A2 (en) | 1996-02-01 |
IL114671A0 (en) | 1995-11-27 |
NO970156D0 (no) | 1997-01-14 |
AU3142295A (en) | 1996-02-16 |
US5776747A (en) | 1998-07-07 |
EP0771350A1 (en) | 1997-05-07 |
US5833979A (en) | 1998-11-10 |
JP2005224614A (ja) | 2005-08-25 |
US5795790A (en) | 1998-08-18 |
TR199500882A2 (tr) | 1996-06-21 |
SK7797A3 (en) | 1997-08-06 |
WO1996002646A3 (en) | 1996-05-17 |
FI970217A (fi) | 1997-01-17 |
NO970156L (no) | 1997-03-20 |
JPH10506266A (ja) | 1998-06-23 |
PL318288A1 (en) | 1997-06-09 |
US5853717A (en) | 1998-12-29 |
AU698624B2 (en) | 1998-11-05 |
CN1152938A (zh) | 1997-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI970217A0 (fi) | Keinotekoisiin biologisiin välineisiin kapseloitujen solujen kasvun säätely | |
DE69329420D1 (de) | In situ implantierter biologischer stromgenerator | |
DE69637669D1 (de) | Myogene differenzierung menschlicher mesenchymaler stammzellen | |
ZA955721B (en) | Methods and compositions of growth control for cells encapsulated within bioartificial organs | |
DE69531399D1 (de) | Kunstherz | |
DE69625119D1 (de) | Stromversorgungsanlage | |
EP0871707A4 (en) | MANIPULATION OF VEGETABLE CELL AND TISSUE CULTURES | |
NO933844L (no) | Kunstig biologisk indresekresjonsanordning | |
DE69703815D1 (de) | Künstliches Zahnimplantat | |
AU5136698A (en) | Materials for growing algae and artificial fishing banks | |
DK238990A (da) | Boelgedrevet kraftanlaeg | |
ATE301472T1 (de) | Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung | |
IT9047689A0 (it) | Struttura per il contenimento di terrapieni naturali e/o artificiali | |
FI973107A0 (fi) | Hallitusti vapautuvat vesiympäristön ravintoaineet | |
DE69814732D1 (de) | Pflanzenwachstumsregulator | |
GB9821193D0 (en) | Mammalian artificial chromosomes and uses thereof | |
FR2598907B1 (fr) | Cheveu artificiel pour l'implantation de cheveux et son procede de preparation | |
FR2630306B1 (fr) | Cheveu artificiel et son procede de preparation | |
DE69812999T2 (de) | Das pflanzenwachstum regulierende zusammensetzung | |
FI972336A (fi) | Biotiinin lisääntynyt biosynteesi kasvisolukossa | |
DE9406589U1 (de) | Mittel zur Verminderung des natürlichen Algenwachstums | |
DE9400720U1 (de) | Stumpfprothese | |
KR970000015A (ko) | 성장식인공수피시술방법 | |
AU2755797A (en) | Transponder-holding case as implant in animal breeding and keeping | |
DE59510758D1 (de) | Naturumlaufreaktor und Verwendung |